R. González del Val

Use of bevacizumab as a first-line treatment for metastatic breast cancer.

F. Moreno, P. Zamora, B. Castelo, 2015, Current oncology.

Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

M. Martín, J. García-Saenz, J. C. de la Torre-Montero, 2018, Breast Cancer Research and Treatment.

Aggressiveness of end-of-life cancer care: what happens in clinical practice?

V. Escudero-Vilaplana, Miguel Martín, M. Sanjurjo, 2020, Supportive Care in Cancer.

Activity and safety of oxaliplatin with weekly 5-fluorouracil bolus and low-dose leucovorin as first-line treatment for advanced colorectal cancer.

V. Guillem, P. Escudero, R. Pérez-Carrión, 2003, Clinical colorectal cancer.

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

J. García-Saenz, F. Moreno, Miguel Martín, 2020, Scientific Reports.

Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

M. Martín, J. García-Saenz, J. C. de la Torre-Montero, 2018, Breast Cancer Research and Treatment.

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

C. Perou, A. Picornell, H. Gómez, 2016, Clinical Cancer Research.

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

C. Perou, A. Picornell, H. Gómez, 2018, Clinical Cancer Research.

Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study.

A. Picornell, J. García-Saenz, F. Moreno, 2019, JCO precision oncology.